Eversept Partners’s Kodiak Sciences KOD Stock Holding History

Eversept Partners’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-181,200	Closed	-$1.4M	–	92
2022 Q1	$1.4M	Buy	+181,200	New	+$7.07M	0.11%	66

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Eversept Partners's KOD Position: Q2 2022 in Review

Eversept Partners sold out of Kodiak Sciences (KOD) in Q2 2022, closing a stake of 91,200 shares — an estimated $704K sold.

Eversept Partners first reported a position in KOD in Q1 2022 and held it in 1 quarter. The position peaked at $704K in Q1 2022. 131 funds tracked by Wall St. Rank hold KOD as of Q2 2022.

Eversept Partners reported no remaining Kodiak Sciences position as of Q2 2022 after selling out during the quarter.
Eversept Partners sold 91,200 Kodiak Sciences shares in Q2 2022, an estimated $704K.
Eversept Partners first reported a position in Kodiak Sciences in Q1 2022 and held it in 1 quarter.
Eversept Partners's Kodiak Sciences position peaked at $704K in Q1 2022.
131 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.